Chrysin pretreatment improves mitochondrial enzymes and angiotensin converting enzymes in L-NAME induced hypertensive rats

Q3 Pharmacology, Toxicology and Pharmaceutics
V. Ramanathan, Swarnalatha Gv Swarnalatha, M. Manimegalai, A. Amalraj, S. Rajagopal
{"title":"Chrysin pretreatment improves mitochondrial enzymes and angiotensin converting enzymes in L-NAME induced hypertensive rats","authors":"V. Ramanathan, Swarnalatha Gv Swarnalatha, M. Manimegalai, A. Amalraj, S. Rajagopal","doi":"10.5530/CTBP.2020.3.34","DOIUrl":null,"url":null,"abstract":"Hypertension is one among the important factors that causes cardiovascular disorders. Nùnitro-L-arginine methyl ester (L-NAME) induces hypertension by blocking nitric oxide (NO) synthesis. Aim of present study was to investigate the effects of chrysin is one of major flavnoids, on L-NAME-induced hypertensive rats. Induces hypertension in adult male wistar rats weighing 180-220 g by oral treated of L-NAME (40 mg/kg/ day) dissolved in drinking water daily for 8 weeks. Experimental rats were oral treated with chrysin (25 mg/kg b.w). Both the systolic and diastolic blood pressure of control and experimental rats were measured by tail cuff plethysmography system. In our studies results showed an increase in the levels of systolic and diastolic blood pressure, heart, liver, kidney, body weight, plasma, and aortic Angiotension converting enzymes (ACE), Sodium (Na+), Chloride (Cl-) levels in LNAME treated rats. At the same time in L-NAME treated rats, there was a decrease in the levels of potassium (K+), Plasma and heartaortic nitrite/ nitrate level, mitochondrial enzymes in liver such as Isocitrate dehydrogenase (ICDH), áketoglutarate dehydrogenase (á-KGDH), Succinate dehydrogenase (SDH) and Malate dehydrogenase (MDH). Chrysin treatment prevented the increase in systolic and diastolic blood pressure in the L-NAME-treated rats. Blood pressure (BP) reduction was interrelated with a reduction in Na+, Cl-, ACE activity and increased K+, plasma and heart, aortic nitrite/nitrate levels. In contrast, L-NAME had opposite effects on mitochondrial liver enzymes, electrolytes, ACE and NO by treatment of chrysin. Hence, the present findings might suggest that chrysin improve the balance between circulating nitric oxide and rennin-angiotensin system and beneficial effects on cardiovascular tissue through its ACE inhibitor activity.","PeriodicalId":10980,"journal":{"name":"Current Trends in Biotechnology and Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Trends in Biotechnology and Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/CTBP.2020.3.34","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Hypertension is one among the important factors that causes cardiovascular disorders. Nùnitro-L-arginine methyl ester (L-NAME) induces hypertension by blocking nitric oxide (NO) synthesis. Aim of present study was to investigate the effects of chrysin is one of major flavnoids, on L-NAME-induced hypertensive rats. Induces hypertension in adult male wistar rats weighing 180-220 g by oral treated of L-NAME (40 mg/kg/ day) dissolved in drinking water daily for 8 weeks. Experimental rats were oral treated with chrysin (25 mg/kg b.w). Both the systolic and diastolic blood pressure of control and experimental rats were measured by tail cuff plethysmography system. In our studies results showed an increase in the levels of systolic and diastolic blood pressure, heart, liver, kidney, body weight, plasma, and aortic Angiotension converting enzymes (ACE), Sodium (Na+), Chloride (Cl-) levels in LNAME treated rats. At the same time in L-NAME treated rats, there was a decrease in the levels of potassium (K+), Plasma and heartaortic nitrite/ nitrate level, mitochondrial enzymes in liver such as Isocitrate dehydrogenase (ICDH), áketoglutarate dehydrogenase (á-KGDH), Succinate dehydrogenase (SDH) and Malate dehydrogenase (MDH). Chrysin treatment prevented the increase in systolic and diastolic blood pressure in the L-NAME-treated rats. Blood pressure (BP) reduction was interrelated with a reduction in Na+, Cl-, ACE activity and increased K+, plasma and heart, aortic nitrite/nitrate levels. In contrast, L-NAME had opposite effects on mitochondrial liver enzymes, electrolytes, ACE and NO by treatment of chrysin. Hence, the present findings might suggest that chrysin improve the balance between circulating nitric oxide and rennin-angiotensin system and beneficial effects on cardiovascular tissue through its ACE inhibitor activity.
金菊素预处理对L-NAME诱导的高血压大鼠线粒体酶和血管紧张素转化酶的影响
高血压是导致心血管疾病的重要因素之一。硝基-L-精氨酸甲酯(L-NAME)通过阻断一氧化氮(NO)的合成诱导高血压。本研究的目的是研究主要黄酮类物质之一白杨素对L-NAME诱导的高血压大鼠的影响。通过每天口服溶于饮用水中的L-NAME(40mg/kg/天),在体重180-220g的成年雄性wistar大鼠中诱导高血压,持续8周。实验大鼠口服白杨素(25mg/kg b.w)。用尾袖容积描记系统测量对照大鼠和实验大鼠的收缩压和舒张压。在我们的研究中,结果显示,LNAME治疗的大鼠的收缩压和舒张压、心脏、肝脏、肾脏、体重、血浆和主动脉血管紧张素转换酶(ACE)、钠(Na+)、氯(Cl-)水平升高。同时,L-NAME处理大鼠的钾(K+)、血浆和心主动脉亚硝酸盐/硝酸盐水平、肝脏线粒体酶如异柠檬酸脱氢酶(ICDH)、α-酮戊二酸脱氢酶(α-KGDH)、琥珀酸脱氢酶(SDH)和马拉特脱氢酶(MDH)水平均下降。赖氨酸治疗阻止了L-NAME治疗大鼠的收缩压和舒张压升高。血压(BP)降低与Na+、Cl-、ACE活性降低以及K+、血浆和心脏、主动脉亚硝酸盐/硝酸盐水平升高有关。相反,赖氨酸处理对线粒体肝酶、电解质、ACE和NO具有相反的影响。因此,目前的研究结果可能表明,白杨素通过其ACE抑制剂活性改善循环一氧化氮和肾素-血管紧张素系统之间的平衡,并对心血管组织产生有益影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Trends in Biotechnology and Pharmacy
Current Trends in Biotechnology and Pharmacy Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
0.70
自引率
0.00%
发文量
0
期刊介绍: The Association of Biotechnology and Pharmacy (ABAP) will be useful to form a forum for scientists so that they can bring together to discuss and find scientific solutions to the problems of society. The annual meetings will help the members to share their knowledge and publish their research knowledge particularly by members and fellows of the Association and special care will be taken to provide an opportunity for young scientists. Besides this the association is planned to organize symposia, seminars and workshops on current developments of Biotechnology and Pharmacy particularly on the subject of current scientific interest, and the proceedings of which will be published regularly. And in view of the vast development of science and to disseminate the problems in publication of research work, an international journal of Current Trends in Biotechnology and Pharmacy has been started by ABAP.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信